Cargando…
The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249980/ https://www.ncbi.nlm.nih.gov/pubmed/32837188 http://dx.doi.org/10.1007/s40267-020-00748-4 |
| _version_ | 1783538689517813760 |
|---|---|
| author | Ogar, C. Mathenge, W. Khaemba, C. Ndagije, H. |
| author_facet | Ogar, C. Mathenge, W. Khaemba, C. Ndagije, H. |
| author_sort | Ogar, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7249980 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72499802020-05-26 The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic Ogar, C. Mathenge, W. Khaemba, C. Ndagije, H. Drugs Ther Perspect Commentary Springer International Publishing 2020-05-26 2020 /pmc/articles/PMC7249980/ /pubmed/32837188 http://dx.doi.org/10.1007/s40267-020-00748-4 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Commentary Ogar, C. Mathenge, W. Khaemba, C. Ndagije, H. The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic |
| title | The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic |
| title_full | The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic |
| title_fullStr | The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic |
| title_full_unstemmed | The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic |
| title_short | The challenging times and opportunities for pharmacovigilance in Africa during the COVID-19 pandemic |
| title_sort | challenging times and opportunities for pharmacovigilance in africa during the covid-19 pandemic |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249980/ https://www.ncbi.nlm.nih.gov/pubmed/32837188 http://dx.doi.org/10.1007/s40267-020-00748-4 |
| work_keys_str_mv | AT ogarc thechallengingtimesandopportunitiesforpharmacovigilanceinafricaduringthecovid19pandemic AT mathengew thechallengingtimesandopportunitiesforpharmacovigilanceinafricaduringthecovid19pandemic AT khaembac thechallengingtimesandopportunitiesforpharmacovigilanceinafricaduringthecovid19pandemic AT ndagijeh thechallengingtimesandopportunitiesforpharmacovigilanceinafricaduringthecovid19pandemic AT ogarc challengingtimesandopportunitiesforpharmacovigilanceinafricaduringthecovid19pandemic AT mathengew challengingtimesandopportunitiesforpharmacovigilanceinafricaduringthecovid19pandemic AT khaembac challengingtimesandopportunitiesforpharmacovigilanceinafricaduringthecovid19pandemic AT ndagijeh challengingtimesandopportunitiesforpharmacovigilanceinafricaduringthecovid19pandemic |